Riskpilot← Back to searchSign inGet full accessLECTINECT AS
ASActiveOrg 982456940Nygårdsgaten 114, 5008 BergenWholesale of pharmaceutical and medical goods · NACE 4646Est. 20000 employeeswww.lectinect.no
Revenue 2021
NOK 58,5M
+7% vs 2020
EBITDA margin
22.1%
+76% vs 2020
Equity ratio
31.1%
Financial strength
Net profit 2021
NOK 10,1M
+77% vs 2020
| Revenue | NOK 58,5M | +7% |
| EBITDA | NOK 12,9M | +76% |
| Net profit | NOK 10,1M | +77% |
| Total assets | NOK 28M | +40% |
| Equity | NOK 8,7M | -9% |
| Employees | 0 | — |
Legal name
LECTINECT AS
Org number
982456940
Legal form
Aksjeselskap
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
23. oktober 2000
Share capital
NOK 857 679 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Utvikling, salg og markedsføring av preparater til styrking av immunforsvaret, helsefremmende produkter, helserelaterte aktiviteter samt hermed beslektet virksomhet.
Address
Nygårdsgaten 114, 5008 Bergen
Website
www.lectinect.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 18 928 | 0 | 19 595 | 21 453 | 24 893 | 29 839 | 34 733 | 31 522 | 40 264 | 45 126 | 43 492 | 34 217 | 54 605 | 58 502 |
| Staff expenses | −0 | −1 787 | −0 | −2 451 | −3 045 | −3 099 | −4 071 | −4 591 | −4 894 | −5 319 | −5 530 | −5 492 | −5 741 | −5 220 | −5 373 |
| EBITDA | 0 | 1 904 | 0 | 2 056 | 1 160 | 2 249 | 3 523 | 3 210 | 4 091 | 3 660 | 1 433 | 3 397 | 3 462 | 7 318 | 12 911 |
| Depreciation & amort. | −0 | −105 | −0 | −75 | −60 | −247 | −22 | −22 | −21 | −0 | −0 | −0 | −0 | −19 | −10 |
| EBIT | 0 | 1 799 | 0 | 1 981 | 1 100 | 2 002 | 3 501 | 3 187 | 4 070 | 3 660 | 1 433 | 3 397 | 3 462 | 7 299 | 12 901 |
| Net financials | 0 | −7 | 0 | 69 | 43 | 77 | 100 | −100 | −62 | −10 | −45 | −97 | 16 | −6 | −1 |
| Profit before tax | 0 | 1 792 | 0 | 2 050 | 1 144 | 2 078 | 3 600 | 3 087 | 4 009 | 3 650 | 1 388 | 3 299 | 3 478 | 7 293 | 12 899 |
| Tax | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −243 | 1 143 | 906 | 323 | 1 288 | 782 | 1 607 | 2 836 |
| Net profit | 0 | 1 792 | 0 | 2 050 | 1 144 | 2 078 | 3 600 | 3 330 | 2 866 | 2 744 | 1 066 | 2 011 | 2 696 | 5 686 | 10 064 |
| Item | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | — | 7 512 | — | 9 755 | 11 039 | 13 149 | 15 483 | 14 541 | 14 441 | 15 116 | 14 884 | 15 657 | 12 432 | 20 031 | 27 983 |
| Equity | — | 4 720 | — | 8 606 | 9 750 | 9 828 | 8 577 | 8 577 | 8 577 | 11 321 | 9 813 | 8 614 | 9 310 | 9 596 | 8 713 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 178 | 246 | 0 | 0 | 0 | 0 |
| Short-term debt | 0 | 2 792 | 0 | 1 149 | 1 289 | 3 320 | 6 906 | 5 964 | 5 864 | 3 618 | 4 825 | 7 043 | 3 122 | 10 435 | 19 271 |
| Total debt | 0 | 2 792 | 0 | 1 149 | 1 289 | 3 320 | 6 906 | 5 964 | 5 864 | 3 796 | 5 070 | 7 043 | 3 122 | 10 435 | 19 271 |
EBITDA margin
22.1%
This company
15.8%
Market median
+40% vs market
20072021
Equity ratio
31.1%
This company
38.2%
Market median
+19% vs market
20072021
Return on equity
115.5%
This company
18.4%
Market median
+528% vs market
20072021
Net profit margin
17.2%
This company
8.1%
Market median
+112% vs market
20072021
Asset turnover
2.09×
This company
1.12×
Market median
+87% vs market
20072021
Debt / equity
2.21×
This company
0.62×
Market median
-256% vs market
20072021
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via Brønnøysundsregistrene · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via Brønnøysundsregistrene · Period 2012-01-01 – 2012-12-31
- Annual report 2011Filed via Brønnøysundsregistrene · Period 2011-01-01 – 2011-12-31
- Annual report 2010Filed via Brønnøysundsregistrene · Period 2010-01-01 – 2010-12-31
- Annual report 2009Filed via Brønnøysundsregistrene · Period 2009-01-01 – 2009-12-31
- Annual report 2008Filed via Brønnøysundsregistrene · Period 2008-01-01 – 2008-12-31
- Annual report 2007Filed via Brønnøysundsregistrene · Period 2007-01-01 – 2007-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
BH Chief Executive Officer | Chief Executive Officer | 2006 | — | — |
AR Deputy Member | Deputy Member | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2019 | — | — | |
| Chairman | 2022 | — | — | |
| Board of Directors | 2019 | — | — | |
| Chairman | 2019 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LECTINECT AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Bjørn Harald Andreassen | Chief Executive Officer | 0 companies |
| Aleksander Rikard Storvestre | Deputy Member | 0 companies |
| Geert Cools | Board of Directors | 0 companies |
| Geir Ivar Westen | Board of Directors | 0 companies |
| Bernard Jean Y Lemaire | Chairman | 0 companies |
| Lars Kristian Gundersen | Board of Directors | 0 companies |
| Rikard Arne Storvestre | Chairman | 0 companies |